Office of Research Integrity

The Office of Research Integrity exists to support the generation and dissemination of knowledge by facilitating safe and compliant research and scholarship.

 
< Back
 

Controlled Substance Use in Non-therapeutic Research

Effective 3/29/2023 - Ohio Board of Pharmacy (OBP) Adopts Emergency Rule Classifying Xylazine as Schedule III Controlled Substance
This is a state action that does not require any additional registration with the U.S. Drug Enforcement Administration (DEA) at this time.

 

Controlled substances are drugs that are regulated by the Drug Enforcement Administration (DEA) and the State of Ohio Board of Pharmacy (OBP) because of potential for abuse. UCORI oversees institutional compliance with the Individual Investigator Use of Controlled Substances in Non-Therapeutic Research policy and procedure. These apply to all individuals obtaining or working with controlled substances in animal research, culture systems, or in vitro laboratory research; it does not apply to human subject research.

UC controlled substance forms and training are located on Research How 2, and UC faculty and staff can find detailed information on our Bearcats Landing intranet page.

Additionally, researchers must be familiar with OBP and DEA guidance prior to registration, including:

 

Contact

Mailing Address

Office of Research Integrity (ML 0567)
University of Cincinnati
University Hall, Suite 540
P.O. Box 2100567
Cincinnati, OH 45221-0567

Street Address

University Hall, Suite 540
51 Goodman Drive
Cincinnati, OH 45221-0567

View on map

General Inquiries

Phone: 513-558-5034

Fax: 513-558-4111

E-mail: integrity@ucmail.uc.edu